A Study of IOV-5001 in Adults With Advanced Solid Tumors

NCT07743723 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
106
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Iovance Biotherapeutics, Inc.